

<!-- page 1 -->

w;s úfYI
wxl 2273$04 - 2022 ud¾;= ui 28 jeks i÷od - 2022'03'28
No. 2273/04 - MoNday,  March  28,  2022
EXTRAORDINARY
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
The Gazette of the Democratic Socialist Republic of Sri Lanka
(Published by Authority)
PART I : SECTION (I) — GENERAL
Government Notifications
1a- G 36470  –  15 (03/2022) 
This Gazette Extraordinary can be downloaded from www.documents.gov.lk
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  
L.D.B. 9/2016 (III).
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
REGULATIONS made by the Minister of health under section 142 of the National Medicines regulatory authority act, 
No. 5 of 2015.
 Dr. Keheliya rambuKwella,
     Minister of health.
colombo,
28th March, 2022.
Regulations
The Medical devices Pricing regulations, No. 01 of 2017 published in the Gazette Extraordinary No. 2006/45 of 
February  17, 2017, as amended by regulations published in Gazette Extraordinary No. 2114/54  of March  15, 2019 
and  regulations published in Gazette Extraordinary No. 2241/43 of august 19, 2021  are hereby further amended 
as follows: -
 
(1) by the repeal of regulation 2 thereof and the substitution therefor, of the following: -
“2. (1) The maximum retail price of the Medical devices described by brand name or approved name specified in 
column II of the Schedule hereto (hereinafter referred to as the “Scheduled Medical devices”) manufactured by such 

<!-- page 2 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
2a
manufacturer specified in corresponding entry in Column III of that Schedule shall be as specified in corresponding entry 
in column IV of the Schedule hereto.
(2) a manufacturer, importer, trader, provider, distributor, pharmacist, medical practitioner, medical institution 
including a private medical institution, pharmacy or person who or which is in possession of the Scheduled Medical 
devices, shall not sell, offer for sale or charge for such Scheduled Medical devices above the maximum retail price 
specified in Column IV   of the Schedule or revised retail price as may be determined in accordance with the provisions 
of regulation 3 (2).”;
(2) by the insertion of the following new regulation immediately after regulation 2 thereof:-
“3 (1) Every trader, provider, distributor, pharmacist, medical practitioner, Medical institution including a private 
medical institution, pharmacy or person who or which is in possession of the Scheduled Medical devices, for the purpose 
of sale shall maintain the price of the Scheduled Medical devices, at the maximum retail price or revised retail price 
whichever is less. 
(2) on the date of publication of these regulations, a manufacturer or importer who sells any Medical devices at a 
revised retail price under the Medical devices (Pricing) regulations, published in Gazette Extraordinary No. 2241/43 
of August 19, 2021 which is less than the maximum retail price specified in Column IV of the Schedule hereto may 
increase proportionately such revised retail price by a total twenty-nine per centum (29%):
Provided however, such increase of revised retail price of the Scheduled Medical devices shall not exceed the 
maximum retail price specified in Column IV of the Schedule hereto.”;
(3) by the repeal of regulation 4 thereof and the substitution therefor, of the following: -
“4. any manufacturer or importer shall print or mark on the commercial package or label of the Scheduled Medical 
devices the maximum retail price specified in Column IV of the Schedule hereto, or the revised retail price, whichever 
is less, in the stock manufactured or available in the market as expeditiously as possible:
Provided however, the maximum retail price or the revised retail price whichever is less shall be printed or 
marked in the commercial package or label of the Scheduled Medical devices before the expiry of a period of forty-five 
days from the date of publication of these regulations.”;
(4) by the repeal of regulation 5 thereof and the substitution therefor, of the following: -
“5. any person who contravenes the provisions of these regulations commits an offence and shall be triable under 
section 131 of the National Medicines regulatory authority act, No. 5 of 2015.”;
(5) by the repeal of regulation 6 thereof and the substitution therefor, of the following: -
“6. It shall be the duty of every manufacturer, importer, trader, provider, distributor, pharmacist, medical practitioner, 
medical institution including a private medical institution, pharmacy or a person who or which is in possession of the 
Scheduled medical devices for the purpose of sale, to display at every retail outlet the maximum retail price of the 
Scheduled medical devices or the revised retail price whichever is less.”;
(6) by the insertion of the following new regulation immediately after regulation 6 thereof:-
“6a. Where any brand name or approved name of the Scheduled Medical devices and the maximum retail price of 
such brand name or approved name of the Scheduled Medical devices are not specified in Column IV of the Schedule 
hereto, the National Medicines Regulatory Authority shall fix the price for the Scheduled Medical devices in such brand 
name or approved name.”;

<!-- page 3 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
3a
(7) by the repeal of regulation 7 thereof and the substitution therefor, of the following: -
“7. In these regulations –
“Medical Practitioner” shall have the same meaning as in the Medical ordinance (chapter 105);
“Person” includes anybody of persons corporate or unincorporate;” and 
“Private Medical Institution” shall have the same meaning as in the Private Medical Institutions (registration) 
act, No. 21 of 2006.”;
(8) by the repeal of the Schedule and the substitution therefor, of the following: -
“SCHEDULE
(Regulation 2)
INTraocULar LENSES/LENSES WITh dELIVEry SySTEM (PrELoadEd/ProVIdEd WITh carTrIdGE)
 Column I Column II Column III Column IV
Brand Name /Approved Name Manufacturer Maximum Retail 
Price  MRP (SLR)
1. AcrySert Preloaded delivery system Alcon Rs. 27,348.00
2. AcrySof IQ SN60WF with cartridge Alcon Rs. 26,378.44
3. Tecnis 1 piece Abbot Medical Rs. 26,055.03
4. enVista Baush & Lomb Rs. 24,930.15
5. Tecnis monofocal Abbot Medical Rs. 24,930.15
6. Hoya iSert 251 Hoya Rs. 19,474.49
7. Nidek Nex-Load system SP SZ–1 Nidek Rs. 19,474.49
8. Aqua Sense Aaris Aaren Scientific Rs. 15,762.38
9. Bi-flex HB (877FABY standard IOL) Medicontur Rs. 14,342.22
10. Bunny HP Hanita Marketing Rs. 13,990.70
11. I-Stream preloaded MD Tech Rs. 11,902.64
12. Aurovue EV Aurolab Rs. 7,965.56
13. AcrySof SP SA60AT with cartridge Alcon Rs. 21,091.50
14. AcrySof EXPAND MA60MA with 
cartridge Alcon Rs. 21,091.50
15. Sensar 1 piece Abbot Medical Rs. 20,592.27

<!-- page 4 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
4a
 Column I Column II Column III Column IV
Brand Name /Approved Name Manufacturer Maximum Retail 
Price  MRP (SLR)
16. Sensar abbot Medical Rs. 18,912.05
17. acrySof MP Ma60ac alcon Rs. 17,210.66
18. hoya Py60r hoya Rs. 12,711.14
19. Acriva UD (blue filter) VSy Biotech Rs. 11,108.19
20. Supra Phob Preloaded system appasamy Rs. 10,461.38
21. acriva Ud VSy Biotech Rs. 10,545.75
22. akreos - MI60 Baush & Lomb Rs. 23,812.30
23. akeros ao Baush & Lomb Rs. 18,658.95
24. akreos adapt Baush & Lomb Rs. 17,435.64
25. Bunny aFM hanita Marketing Rs. 17,084.12
26. cT asphina 404 carl Zeiss Meditec Rs. 16,873.20
27. cT Spheris 204 carl Zeiss Meditec Rs. 13,189.22
28. Bunny aF hanita Marketing Rs. 11,586.26
29. c-Flex aspheric 970c/920h rayner Rs. 9,702.09
30. aspira-aay human optics Rs. 9,167.77
31. ocuva VSy Biotech Rs. 6,439.94
32. Auroflex aurolab Rs. 2,896.57
33. Seelens hanita Marketing Rs. 9,976.28
34. c–Flex IoL (Spherical 570c) rayner Rs. 8,225.69
35. aspira aS human optics Rs. 8,366.30
36. Tecsoft Tetra Fred hollows Rs. 7,733.55
37. Tecsoft Flex Fred hollows Rs. 7,241.42
38. acryfold appasamy Rs. 4,921.35
EOG 03-1012/1

<!-- page 5 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
5a
L.D.B. 9/2016 (III)
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
REGULATIONS made by the Minister of health under section 142 of the National Medicines regulatory authority act, 
No. 5 of 2015.
 Dr. Keheliya rambuKwella,
     Minister of health.
colombo,
28th March, 2022.
Regulations
   The Medical devices Pricing regulations, No. 05 of 2017, published in the Gazette Extraordinary No. 2030/47 of 
august  04, 2017, as amended by regulations published in Gazette Extraordinary No. 2114/54  of March  15, 2019 and  by 
regulations published in Gazette Extraordinary No. 2241/43 of august 19, 2021 are hereby further amended as follows : -
(1) by the repeal of regulation 2 thereof and the substitution therefor, of the following: -
“2. (1) The maximum retail price of the Medical devices specified in Column I of the Schedule hereto (hereinafter 
referred to as the “Scheduled Medical devices”) described by any brand name, models, sizes or pack sizes, shall be as 
specified in corresponding entry in Column II of the Schedule hereto.
(2) a manufacturer, importer, trader, provider, distributor, pharmacist, medical practitioner, medical institution 
including a private medical institution, pharmacy or person who or which is in possession of the Scheduled Medical 
devices, shall not sell, offer for sale or charge for such Scheduled Medical devices above the maximum retail price 
specified in Column II of the Schedule or revised retail price as may be determined in accordance with the provisions 
of regulation 3 (2).”;
(2)  by the repeal of regulation 3  thereof and the substitution therefor, of the following: -
“ 3. (1) Every trader, provider, distributor, pharmacist, medical practitioner, Medical institution including a private 
medical institution, pharmacy or person who or which is in possession of the Scheduled Medical devices, for the purpose 
of sale shall maintain the price of the Scheduled Medical devices, at the maximum retail price or revised retail price 
whichever is less.
(2) on the date of publication of these regulations, a manufacturer or importer who sells any Medical devices at a 
revised retail price under the Medical devices (Pricing) regulations, published in Gazette Extraordinary No. 2241/43 of 
August 19, 2021 which is less than the maximum retail price specified in Column II of the Schedule hereto may increase 
proportionately such revised retail price by a total twenty-nine per centum (29%):
Provided however, such increase of revised retail price of the Scheduled Medical devices shall not exceed 
the maximum retail price specified in Column II of the Schedule hereto.”;
(3)  by the repeal of regulation 5 thereof and the substitution therefor, of the following:
“5. any manufacturer or importer shall print or mark on the commercial package or label of the Scheduled Medical 
devices the maximum retail price specified in Column II of the Schedule hereto, or the revised retail price, whichever is 
less, in the stock manufactured or available in the market as expeditiously as possible:

<!-- page 6 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
6a
Provided however, the maximum retail price or the revised retail price whichever is less shall be printed or 
marked in the commercial package or label of the Scheduled Medical devices before the expiry of a period of forty-five 
days from the date of publication of these regulations.”;
(4) by the repeal of regulation 6 thereof and the substitution therefor, of the following: -
“6. any person who contravenes the provisions of these regulations commits an offence and shall be triable under 
section 131 of the National Medicines regulatory authority act, No. 5 of 2015.”;
(5)  by the repeal of regulation 7 thereof and the substitution therefor, of the following: -
“7. It shall be the duty of every manufacturer, importer, trader, provider, distributor, pharmacist, medical practi -
tioner, medical institution including a private medical institution, pharmacy or a person who or which is in possession 
of the Scheduled medical devices for the purpose of sale, to display at every retail outlet the maximum retail price of 
the Scheduled medical devices or the revised retail price whichever is less.”;
(6) by the insertion of the following new regulation immediately after regulation 7 thereof :-
“8. Where any brand name, model, size or pack size of the Scheduled Medical devices and the maximum retail price 
of such brand name, model, size or pack size of the Scheduled Medical devices are not specified in Column II of the 
Schedule hereto, the National Medicines Regulatory Authority shall fix the price for the Scheduled Medical devices in 
such brand name, model, size or pack size.”;
(7) by the repeal of regulation 8 thereof and the substitution therefor, of the following: -
“9. In these regulations –
“Medical Practitioner” shall have the same meaning as in the Medical ordinance (chapter 105);
“Person” includes any body of persons corporate or unincorporate ; and 
“Private Medical Institution” shall have the same meaning as in the Private Medical Institutions (registration) 
act, No. 21 of 2006.”;
(8) by the repeal of the Schedule and the substitution therefor, of the following: -
SCHEDULE
(Regulation 2)
No. Column I Column II
Item Maximum Retail Price (MRP)
(SLR)
1. Bare Metal Stent Rs. 38,597.45
2. drug Eluting Stent Rs. 168,732.00
EOG 03-1012/2

<!-- page 7 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
7a
L.D.B. 9/2016 (III)
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
REGULATIONS made by the Minister of health under section 142 of the National Medicines regulatory authority act, 
No. 5 of 2015.
 Dr. Keheliya rambuKwella,
     Minister of health.
colombo,
28th March, 2022.
Regulations
The Medical devices (Pricing) regulations, 2018 published in the Gazette Extraordinary No. 2086/37 of august  
31, 2018, as amended by regulations published in Gazette Extraordinary No. 2114/54  of March  15, 2019 and by 
regulations published in Gazette Extraordinary No. 2241/43 of august 19, 2021 are hereby  further amended as 
follows: -
(1) by the repeal of regulation 2 thereof and the substitution therefor, of the following: -
“2. (1) The maximum retail price of the Medical devices in approved name specified in Column I of the Schedule 
hereto (hereinafter referred to as the “Scheduled Medical devices”) described by any brand name, models, sizes or 
pack sizes, shall be as specified in corresponding entry in Column II of the Schedule hereto.
(2)  a manufacturer, importer, trader, provider, distributor, pharmacist, medical practitioner, medical 
institution including a private medical institution, pharmacy or person who or which is in possession of the Scheduled 
Medical devices, shall not sell, offer for sale or charge for such Scheduled Medical devices above the maximum 
retail price specified in Column II  of the Schedule or revised retail price as may be determined in accordance with 
the provisions of regulation 3 (2).”;
(2) by the repeal of regulation 3  thereof and the substitution therefor, of the following: -
“3 (1) Every trader, provider, distributor, pharmacist, medical practitioner, Medical institution including a 
private medical institution, pharmacy or person who or which is in possession of the Scheduled Medical devices, 
for the purpose of sale shall maintain the price of the Scheduled Medical devices, at the maximum retail price or 
revised retail price whichever is less.
(2) on the date of publication of these regulations, a manufacturer or importer who sells any Medical devices 
at a revised retail price under the Medical devices (Pricing) regulations, published in Gazette Extraordinary No. 
2241/43 of August 19, 2021 which is less than the maximum retail price specified in Column II of the Schedule 
hereto may increase proportionately such revised retail price by a total twenty-nine per centum (29%): 
Provided however, such increase of revised retail price of the Scheduled Medical devices shall not 
exceed the maximum retail price specified in Column II of the Schedule hereto.”;
(3) by the repeal of regulation 5 thereof and the substitution therefor, of the following:
“5. any manufacturer or importer shall print or mark on the commercial package or label of the Scheduled 
Medical devices the maximum retail price specified in Column II of the Schedule hereto, or the revised retail price, 
whichever is less, in the stock manufactured or available in the market as expeditiously as possible:

<!-- page 8 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
8a
Provided however, the maximum retail price or the revised retail price whichever is less shall be printed 
or marked in the commercial package or label of the Scheduled Medical devices before the expiry of a period of 
forty-five days from the date of publication of these regulations.”;
(4) by the repeal of regulation 6 thereof and the substitution therefor, of the following: -
“6. any person who contravenes the provisions of these regulations commits an offence and shall be triable 
under section 131 of the National Medicines regulatory authority act, No. 5 of 2015.”;
(5) by the repeal of regulation 7 thereof and the substitution therefor, of the following: -
“7. It shall be the duty of every manufacturer, importer, trader, provider, distributor, pharmacist, medical 
practitioner, medical institution including a private medical institution, pharmacy or a person who or which is in 
possession of the Scheduled medical devices for the purpose of sale, to display at every retail outlet the maximum 
retail price of the Scheduled medical devices or the revised retail price whichever is less.”;
(6)  by the repeal of regulation 8 thereof and the substitution therefor, of the following: -
“8. Where any brand name, model, size or pack size of the Scheduled Medical devices and the maximum retail 
price of such brand name, model, size or pack size of the Scheduled Medical devices are not specified in Column II 
of the Schedule hereto, the National Medicines Regulatory Authority shall fix the price for the Scheduled Medical 
devices in such brand name, model, size or pack size.”;
(7) by the insertion of definition for the term of expression “person”, immediately after definition of “medical practi-
tioner”:-
““ person” includes any body of persons corporate or unincorporate;”; and 
(8)  by the repeal of the Schedule and the substitution therefor, of the following: -
“SCHEDULE”
(Regulation 2)
 MAXIMUM RETAIL PRICES OF TWO SELECTED MEDICAL DEVICES
No. Column I Column II
Approved Name Maximum Retail Price (MRP)
(SLR)
1. BLOOD GLUCOSE MONITORING SYSTEM 4,429.22 
Per Unit
2. TEST STRIPS FOR BLOOD GLUCOSE MONITORING SYSTEM 80.15 
Per Strip
EOG 03-1012/3

<!-- page 9 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
9a
L.D.B. 9/2016 (III)
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
REGULATIONS made by the Minister of health under section 142 of the National Medicines regulatory authority act, 
No. 5 of 2015.
 Dr. Keheliya rambuKwella,
     Minister of health.
colombo,
28th March, 2022.
Regulations
   The Medical (Pricing of Medical devices) regulations No. 1 of 2021 published in the Gazette Extraordinary                         
No. 2243/20 of September 04, 2021 is hereby amended as follows :-
(1) by the repeal of regulation 2 thereof and the substitution therefor, of the following: -
“2 (1) The maximum retail price of the Medical device in approved name specified in Column I of the Schedule 
hereto (hereinafter referred to as the “Scheduled Medical device”) described by any brand name, models, sizes or pack 
sizes, shall be as specified in corresponding entry in Column II of the Schedule hereto.
(2) a manufacturer, importer, trader, provider, distributor, pharmacist, medical practitioner, medical institution 
including a private medical institution, pharmacy or person who or which is in possession of the Scheduled Medical 
device, shall not sell, offer for sale or charge for such Scheduled Medical device above the maximum retail price spec-
ified in Column II  of the Schedule or revised retail price as may be determined in accordance with the provisions of 
sub regulation (4) of this regulation.
(3) Every trader, provider, distributor, pharmacist, medical practitioner, Medical institution including a private 
medical institution, pharmacy or person who or which is in possession of the Scheduled Medical device, for the purpose 
of sale shall maintain the price of the Scheduled Medical device, at the maximum retail price or revised retail price 
whichever is less.
(4) on the date of publication of these regulations, a manufacturer or importer who sells any Medical device at a 
revised retail price under the Medical (Pricing of Medical devices) regulations No. 1 of 2021 published in the Gazette 
Extraordinary No. 2243/20 of September 04, 2021 which is less than the maximum retail price specified in Column II 
of the Schedule hereto may increase proportionately such revised retail price by a total twenty-nine per centum (29%): 
Provided however, such increase of revised retail price of the Scheduled Medical device shall not exceed the 
maximum retail price specified in Column II of the Schedule hereto.”;
(2) by the repeal of regulations 3 and 4 thereof and the substitution therefor, of the following: -
“3. any manufacturer or importer shall print or mark on the commercial package or label of the Scheduled Medical 
device the maximum retail price specified in Column II of the Schedule hereto, or the revised retail price, whichever is 
less, in the stock manufactured or available in the market as expeditiously as possible:
Provided however, the maximum retail price or the revised retail price whichever is less shall be printed or 
marked in the commercial package or label of the Scheduled Medical device before the expiry of a period of forty-five 
days from the date of publication of these regulations.”;

<!-- page 10 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2022'03'28
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 28.03.2022
10a
(3) by the repeal of regulation 6  thereof and the substitution therefor, of the following: -
“6. It shall be the duty of every manufacturer, importer, trader, provider, distributor, pharmacist, medical practi -
tioner, medical institution including a private medical institution, pharmacy or a person who or which is in possession 
of the Scheduled medical device for the purpose of sale, to display at every retail outlet the maximum retail price of the 
Scheduled medical device or the revised retail price whichever is less.”;
(4)  by the repeal of regulation 8 thereof and the substitution therefor, of the following: -
“8. Where any brand name, model, size or pack size of the Scheduled Medical device and the maximum retail price 
of such brand name, model, size or pack size of the Scheduled Medical device are not specified in Column II of the 
Schedule hereto, the National Medicines Regulatory Authority shall fix the price for the Scheduled Medical device in 
such brand name, model, size or pack size.”;
(5) by the repeal of regulation 9 thereof and the substitution therefor, of the following: -
“9. any person who contravenes the provisions of these regulations commits an offence and shall be triable under 
section 131 of the National Medicines regulatory authority act, No. 5 of 2015.”;
(6) by the repeal of regulation 10 thereof and the substitution therefor, of the following:-
“10. In these regulations –
“Medical Practitioner” shall have the same meaning as in the Medical ordinance (chapter 105);
““Person” includes any body of persons corporate or unincorporate ;” and 
“Private Medical Institution” shall have the same meaning as in the Private Medical Institutions (registration) 
act, No. 21 of 2006.
SCHEDULE
(Regulation 2)
MAXIMUM RETAIL PRICE OF SELECTED MEDICAL DEVICE
No. Column I Column II
Approved Name Maximum Retail Price per unit (MRP)
(SLR)
1. Pulse Oximeter Rs. 3870.00
EOG 03-1012/4
PrINTEd  aT  ThE  dEParTMENT  oF  GoVErNMENT  PrINTING,  SrI  LaNka.